Targeted inhibition of CaN/NFAT signaling, either by naturally occurring compounds or synthetic drugs, may effectively reduce neuroinflammation, thus offering a promising strategy in the treatment of AD (220, 221). This evidence concerns the gene NUP214 and Alzheimer disease.